Amaran Moodley

Dedicated to building bridges between disciplines in the realm of pediatric infectious diseases, Amaran Moodley serves as an Associate Clinical Professor in Pediatrics at the Medicine University of California-San Francisco. His research is primarily centered on understanding the multifaceted clinical and demographic factors associated with COVID-19, with a particular focus on severe COVID-19 and SARS-CoV-2 infections in adults. Dr. Moodley has played a pivotal role in evaluating the efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine across various age groups, including children, thereby contributing significantly to the global fight against the pandemic. His research extends beyond COVID-19, encompassing a wide array of infectious diseases that affect the pediatric population. In addition to his work on COVID-19, Dr. Moodley has made substantial contributions to the study of congenital infections and has explored the complexities of tuberculosis-associated acute disseminated encephalomyelitis. His investigations into the antiviral treatment of childhood influenza further underscore his dedication to advancing pediatric healthcare. Dr. Moodley's scholarly contributions are reflected in his numerous publications, which have been instrumental in shaping current understanding and treatment approaches in pediatric infectious diseases. His work not only enhances clinical practices but also informs public health strategies aimed at protecting vulnerable populations. Through his research and teaching, Dr. Moodley is committed to fostering a deeper understanding of infectious diseases and improving health outcomes for children worldwide. His dedication to vaccine research and infectious disease prevention continues to inspire both his colleagues and students at the university.